Neoplasms

All Conditions

Digestive System Diseases

Symptoms and General Pathology

Gland and Hormone Related Diseases

Nervous System Diseases

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Respiratory Tract (Lung and Bronchial) Diseases

Rare Diseases

Carcinoma

Esophageal Neoplasms

Fatigue

Pancreatic Neoplasms

Sarcoma

Head and Neck Neoplasms

Brain Neoplasms

Uterine Neoplasms

Carcinoma, Bronchogenic

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Gastrointestinal Neoplasms

Digestive System Neoplasms

Endocrine Gland Neoplasms

Gastrointestinal Diseases

Pancreatic Diseases

Endocrine System Diseases

Esophageal Diseases

Bronchial Neoplasms

Lung Neoplasms

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Genital Neoplasms, Female

Urogenital Neoplasms

Uterine Diseases

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Esophageal Cancer

Pancreatic Cancer

Soft Tissue Sarcoma

Central Nervous System Depressants

All Drugs and Chemicals

Other Dietary Supplements

Benzocaine

Tannic Acid

Patients receive a fitness tracker, a booklet "Physical training, exercise and cancer" and an in-person briefing on physical activity during cancer therapy. We suggest a daily step-count which should improve the patients phyiscal activity during radiotherapy of breast cancer. Patients receive weekly feedback and a new goal with the aim to reach a total of 6000 daily steps, which should be then maintained during radiotherapy.

Patients receive a fitness tracker, a booklet "Physical training, exercise and cancer" and an in-person briefing on physical activity during cancer therapy.

The patients self-document their daily step count during radiotherapy, there will be no recommendation for the daily count of steps.

Patients receive a booklet "Physical training, exercise and cancer" and an in-person briefing on physical activity during cancer therapy. A fitness tracker will not be provided.

Patients receive a fitness tracker, a booklet "Physical training, exercise and cancer" and an in-person briefing about physical activity during cancer therapy. With offered guidelines for the daily step counts patients should improve their physical activity during radiotherapy of breast cancer. A weekly feedback and a new goal for the next week will be provided until the individual patient reaches a daily activity of 6000 steps. The setting will be to maintain to this daily activity of 6000 steps during radiotherapy.

Fitness tracker based activity training for Arm A and B. Booklet "physical training, exercise and cancer" and an introduction about physical activity during cancer therapy for Arm A, B, C

Cihan Gani, MD, PD

Daniel Zips, MD, Prof.

Evaluation of the impact of an activity tracker based fitness programme on the Qualitiy of Life after oncological therapy.

This monocentric, three-arm, randomized, controlled clinical trial evaluates the effect of an activity tracker based exercise program in cancer patients on the Quality of life after oncological therapy. Quality of Life and the intensity of fatigue will be documented with the FACT-G total score of the FACIT Questionnaire six months after completion of radiotherapy.

Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy

Randomisierte Studie Zum Nutzen Eines Fitnesstracker Basierten Aktivitätstrainings während Einer Strahlentherapeutischen Behandlung (OnkoFit II Studie)

This endpoint will be evaluated by the FACT-G (Functional Assessment of Cancer Therapy - General) total scores of the FACIT (Functional Assessment of Chronic Illness Therapy) questionnaire (physical well-being values 0-28, 28 worse outcome; social/family well-being values 0-28, 28 better outcome; emotional well-being values 0-24, 24 worse outcome; functional well-being values 0-28, 28 better outcome

University Hospital Tuebingen

Senior Physician

Blood and Lymph Conditions

Immune System Diseases

Nutritional and Metabolic Diseases

Body Weight

Muscular Atrophy

Lymphoma

Weight Loss

Hodgkin Disease

Wasting Syndrome

Cachexia

Lymphoproliferative Disorders

Lymphatic Diseases

Immunoproliferative Disorders

Body Weight Changes

Lymphosarcoma

Hodgkin Lymphoma

Anti-Infective Agents

Respiratory System Agents

Acetylcysteine

N-monoacetylcystine

Antioxidants

Antiviral Agents

Expectorants

Protective Agents

Antidotes

N-acetylcysteine

Wulf Hildebrandt, MD

The purpose of the study is to tests the hypothesis, that N-acetylcysteine (a thiol-antioxidant)improves the exercise training effect on cancer patients that experience weight loss (cachexia) as assessed by muscle mass and function as well as histomorphology.

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

Effect of N-Acetylcysteine on Skeletal Muscle in Cachectic Cancer Patients Undergoing a Resistance Training Program (Phase 2 Study)

Heidelberg University

German Cancer Research Center

Neuroendocrine Tumors

Neuroendocrine Tumor

Patients with lung cancer requiring therapy

Hans-Werner Tessen, MD

Overview of treatment reality in patients with bronchial carcinoma requiring systemic treatment and being treated by office-based oncologists in Germany.

The TLK is a prospective, longitudinal, nation wide cohort study that collects data on the treatment reality of patients with NSCLC and SCLC. At inclusion, data in patient characteristics, comorbidities, tumor characteristics, biomarker testing and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Patients are followed until death or for a maximum of 3 years.

Tumour Registry Lung Cancer (TLK)

Clinical Registry Describing Treatment Reality and Therapy Modalities of Patients With Lung Cancer (NSCLC, SCLC and Neuroendocrine Tumors) Requiring Therapy.

iOMEDICO AG

Behaviors and Mental Disorders

Syndrome

Apnea

Sleep Apnea Syndromes

Respiration Disorders

Signs and Symptoms, Respiratory

Parasomnias

Sleep Disorders, Intrinsic

Dyssomnias

Sleep Wake Disorders

This is the only group in the present study. Patients with bronchial carcinoma (or reasonable suspicion) perform sleep screening with ApneaLinkTM at home or during the hospitalization.

ApneaLink is sleep-screening tool that objectively identifies patients with sleep apnea

sleep apnea screening with ApneaLinkTM

Angela Habier

Michael Dreher, Univ.-Prof.

Tobias Müller, PD Dr. med.

Hendrik Storre, PD.Dr.

Krüger Stefan, Prof.

In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.

Determination of the SAS- frequence in patients with bronchial carcinoma. The patients will be screened at home for 1 night with the ApneaLink device by ResMed. The apneaLink device is a standard screening tool for sleep apnea in clinical practice.

SAS in Patients With Bronchial Carcinoma

Incidence of Sleep Apnea Syndrome (SAS) in Patients With Bronchial Carcinoma

The percent of sleep apnea in a cohort of patients with bronchial carcinoma will be evaluated. The duration of the study participation is two days.

RWTH Aachen University

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy	NCT04517019	Bronchial Carci... Esophageal Carc... Tumor of the Br... Head and Neck C... Pancreas Cancer Sarcoma Cervix Uteri Ca...	Fitness tracker...	18 Years -	University Hospital Tuebingen
Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training	NCT00196885	Gastrointestina... Bronchial Carci... Hodgkin Disease Non-Hodgkin Lym... Weight Loss	N-acetylcystein...	20 Years - 80 Years	German Cancer Research Center
Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training	NCT00196885	Gastrointestina... Bronchial Carci... Hodgkin Disease Non-Hodgkin Lym... Weight Loss	N-acetylcystein...	20 Years - 80 Years	German Cancer Research Center
Tumour Registry Lung Cancer (TLK)	NCT01192919	Lung Cancer		18 Years -	iOMEDICO AG
SAS in Patients With Bronchial Carcinoma	NCT02270853	Sleep Apnea Syn... Bronchial Carci...	sleep apnea scr...	18 Years -	RWTH Aachen University

Spots Global Cancer Trial Database for bronchial carcinoma